Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma.
about
Liver resection for intermediate hepatocellular carcinomaPost-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinomaAnalysis of liver-directed therapies in U.S. cancer patients.Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma.
P2860
Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Expanded use of aggressive the ...... iate hepatocellular carcinoma.
@ast
Expanded use of aggressive the ...... iate hepatocellular carcinoma.
@en
type
label
Expanded use of aggressive the ...... iate hepatocellular carcinoma.
@ast
Expanded use of aggressive the ...... iate hepatocellular carcinoma.
@en
prefLabel
Expanded use of aggressive the ...... iate hepatocellular carcinoma.
@ast
Expanded use of aggressive the ...... iate hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Expanded use of aggressive the ...... iate hepatocellular carcinoma.
@en
P2093
Alexander Monto
Carlos U Corvera
Edith Y Ho
Erica Trimble
HOVAS Group (Hepatocellular Carcinoma Treatment Outcome at VA San Francisco)
James C Ryan
Myrna L Cozen
Robert Lerrigo
P2860
P304
P356
10.1111/HPB.12214
P577
2014-01-28T00:00:00Z